Related Experiment Video
Updated: Jun 4, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the
Andrew D Krahn1, Douglas S Lee, David Birnie
1Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. akrahn@uwo.ca
Insights
Complications after implantable cardioverter-defibrillator (ICD) replacement are linked to angina, antiarrhythmic drugs, prior procedures, and low implanter volume. These major complications increase the risk of mortality.
Area of Science:
- Cardiology
- Medical Devices
- Patient Safety
Background:
- Implantable cardioverter-defibrillator (ICD) replacement complications can be severe, especially infections or reoperations.
- Identifying high-risk patients for ICD replacement is crucial for targeted monitoring and therapy.
- Predictive factors for adverse outcomes can aid clinical decision-making for ICD replacement.
Purpose of the Study:
- To identify risk factors for complications following ICD generator replacement.
- To assess the association between ICD replacement complications and subsequent mortality.
Main Methods:
- Prospective, multicenter, population-based registry of ICD patients in Ontario, Canada (February 2007 - August 2009).
- Examined 45-day complication and all-cause mortality rates after ICD generator replacement in 1081 patients.
- Multivariable analysis and Cox models were used to identify risk factors and mortality associations.
Main Results:
- 4.3% of patients experienced complications within 45 days of ICD replacement; 2.6% had major complications (most common: infection, lead revision).
- Risk factors for major complications included Canadian Cardiovascular Society angina class and multiple previous pocket procedures.
- Risk factors for any complication included antiarrhythmic therapy, low implanter volume, and angina class.
Conclusions:
- Angina, antiarrhythmic therapy, prior procedures, and low implanter volume are associated with ICD replacement complications.
- Major complications after ICD replacement are linked to an increased risk of mortality at 45, 90, and 180 days.
Background:
Complications after implantable cardioverter-defibrillator (ICD) replacement are often clinically devastating, particularly when infection or reoperation occurs. Identifying factors contributing to complications may permit identification of high-risk individuals that warrant incremental monitoring and therapy to attenuate risk. In addition, replacement may be a discretionary decision in the context of an advisory or borderline device performance and patient, device, and implanter factors that predict adverse outcome may assist in clinical decision-making.
Methods And Results:
In a prospective, multicenter, population-based registry of all ICD patients at 18 centers in Ontario, Canada, we examined 45-day complication and all-cause mortality rates from February 2007 to August 2009 in patients undergoing ICD generator replacement. Complications were determined longitudinally and were categorized as major or minor. ICD replacement was performed in 1081 of 5176 patients (20.8%) undergoing ICD implantation (age, 64.3±12.7 years; 78.5% men). In patients undergoing ICD replacement, 47 patients (4.3%) had a complication within 45 days, with 47 major complications in 28 patients (2.6%), most commonly infection (n=23), lead revision (n=35), electrical storm (n=14), and pulmonary edema (n=13). Minor complications occurred in 2.3% of patients, most commonly incisional infection (n=10) and pocket hematoma (n=10). On multivariable analysis, risk factors associated with major complications were Canadian Cardiovascular Society angina class (adjusted hazard ratio [HR], 3.70 for class 2 to 4 versus 0 to 1; P=0.027) and multiple previous procedures on the pocket (adjusted HR, 3.35 for >1 versus 1; P=0.058). Risk factors associated with any complication were the use of antiarrhythmic therapy (adjusted HR, 6.29; P=0.001), implanter volume (adjusted HR 10.4 for <60/y versus >120/y, P=0.026), and Canadian Cardiovascular Society angina class (adjusted HR, 3.00 for class 2 to 4 versus 0 to 1; P=0.031). In a Cox model with a time-dependent variable of major complication within 45 days after replacement, major complications after ICD replacement were associated with an increased risk of mortality at 45, 90, and 180 days (adjusted HR, 9.61, 12.69, and 6.41, respectively; P=0.002 to 0.039).
Conclusions:
Risk factors associated with complications after ICD replacement include the presence of angina, antiarrhythmic therapy, increased number of previous procedures, and low implanter volume. Major complications may be associated with increased risk of subsequent mortality.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Cardiac Catheterization I: Pre-Procedure Overview
